Chemistry Ventures
SlowingFiled to raiseSan Francisco, CABiotechnology, Banking, Tourism and Travel ServicesLast fund filed 2026
3 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Chemistry Ventures Fund II-A | June 2026 | $10M | $10M | 2 |
| Chemistry Ventures Fund IIFiled to raise in 2026, with no closing reported yet. | 2026 | $500M | $0 | 0 |
| Chemistry Ventures Fund I | October 2024 | $355M | $355M | 74 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
3 partners are named across this firm’s filings, 3 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Mark Goldberg | Slowing | Biotech & pharma, Fintech, Digital health | 7 |
Classified sectors of Chemistry Ventures’s own portfolio companies, based on 16 with a verified or cited source.
| Firm | Shared boards | Companies |
|---|---|---|
| Bessemer Venture Partners | 6 | Hightower, npm, PagerDuty, PinPT, Simply Measured, View The Space |
| Kleiner Perkins | 2 | Motive Technologies, Pilot.com |
| Addition Five | 1 | Built Technologies |
| Addition Four |
| 1 |
| Ethan Kurzweil | Quiet | Developer tools & infrastructure, Enterprise software, Real estate & proptech | 6 | 0 |
| Kristina Shen | Quiet | Developer tools & infrastructure, Enterprise software | 4 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Chemistry Ventures’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| 1 |
| Built Technologies |
| Addition One | 1 | Built Technologies |
| Addition Six | 1 | Built Technologies |
| Addition Three | 1 | Built Technologies |
| Addition Two | 1 | Built Technologies |
| Claremount VII Associates | 1 | Hightower |
| Domain Partners | 1 | aTYR PHARMA |
| Insight | 1 | View The Space |
| Institutional Venture Partners | 1 | Motive Technologies |
| Openview Venture Partners | 1 | View The Space |
| Polaris Partners | 1 | aTYR PHARMA |
| RRE Ventures | 1 | Hightower |
A shared board seat: a company where filings name a Chemistry Ventures partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.